• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Minimally Invasive Surgery Devices Market

    ID: MRFR/HC/16530-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Minimally Invasive Surgery Devices Market

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Minimally Invasive Surgery Devices Market Infographic
    Purchase Options

    US Minimally Invasive Surgery Devices Market Summary

    As per MRFR analysis, the US minimally invasive-surgery-devices market size was estimated at 1650.0 USD Million in 2024. The US minimally invasive-surgery-devices market is projected to grow from 1807.57 USD Million in 2025 to 4500.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 9.55% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US minimally invasive surgery devices market is poised for robust growth driven by technological advancements and increasing patient demand.

    • Technological advancements are enhancing the efficacy and safety of minimally invasive surgical procedures.
    • The outpatient procedure segment is experiencing rising demand due to its cost-effectiveness and shorter recovery times.
    • Regulatory support for innovation is fostering the development of new surgical devices and techniques.
    • Key market drivers include the increasing prevalence of chronic diseases and growing awareness among patients.

    Market Size & Forecast

    2024 Market Size 1650.0 (USD Million)
    2035 Market Size 4500.0 (USD Million)

    Major Players

    Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)

    US Minimally Invasive Surgery Devices Market Trends

    the market is currently experiencing notable growth, driven by advancements in technology and increasing patient demand for less invasive procedures. These devices, which include tools such as laparoscopes, robotic surgical systems, and endoscopes, are becoming more sophisticated, allowing for greater precision and reduced recovery times. As healthcare providers seek to enhance patient outcomes, the adoption of these devices is likely to rise, reflecting a shift towards more efficient surgical practices. Furthermore, the aging population in the US is contributing to a higher prevalence of chronic diseases, which in turn fuels the need for minimally invasive surgical interventions. In addition, regulatory bodies are actively promoting the development and approval of innovative surgical devices, which may further stimulate market growth. The integration of artificial intelligence and robotics into surgical procedures appears to be a significant trend, enhancing the capabilities of surgeons and improving overall surgical performance. As the healthcare landscape evolves, the minimally invasive-surgery-devices market is poised for continued expansion, driven by technological advancements and changing patient preferences.

    Technological Advancements

    The minimally invasive-surgery-devices market is witnessing rapid technological innovations, particularly in robotic-assisted surgery and imaging techniques. These advancements enhance surgical precision and reduce complications, leading to improved patient outcomes. As technology continues to evolve, the market is likely to see an influx of new devices that offer enhanced functionality and ease of use.

    Rising Demand for Outpatient Procedures

    There is a growing trend towards outpatient surgical procedures, which are often facilitated by minimally invasive techniques. This shift is driven by patient preferences for shorter recovery times and reduced hospital stays. As healthcare systems adapt to this demand, the minimally invasive-surgery-devices market is expected to expand, providing more options for outpatient care.

    Regulatory Support for Innovation

    Regulatory agencies are increasingly supporting the development of new minimally invasive surgical devices through streamlined approval processes. This support encourages innovation and allows for quicker market entry of advanced technologies. As a result, the minimally invasive-surgery-devices market may experience accelerated growth, with more innovative solutions becoming available to healthcare providers.

    US Minimally Invasive Surgery Devices Market Drivers

    Rising Healthcare Expenditure

    The increasing healthcare expenditure in the US is a significant driver for the minimally invasive-surgery-devices market. With healthcare spending projected to reach $6 trillion by 2027, there is a growing investment in advanced surgical technologies. This financial commitment allows hospitals and surgical centers to acquire state-of-the-art minimally invasive devices, enhancing their surgical capabilities. Furthermore, as healthcare systems strive to improve patient outcomes while managing costs, minimally invasive procedures are often seen as a cost-effective solution. This trend indicates a robust market potential as healthcare providers seek to optimize their surgical offerings.

    Supportive Reimbursement Policies

    Supportive reimbursement policies for minimally invasive procedures are playing a crucial role in the growth of the minimally invasive-surgery-devices market. Insurance companies are increasingly recognizing the benefits of these procedures, leading to favorable reimbursement rates. This trend encourages healthcare providers to adopt minimally invasive techniques, as they can offer patients effective solutions without significant financial burdens. As reimbursement policies continue to evolve, they are likely to further incentivize the use of minimally invasive devices, thereby expanding the market. The alignment of financial incentives with patient care objectives suggests a promising outlook for the industry.

    Increasing Prevalence of Chronic Diseases

    The rising incidence of chronic diseases such as cardiovascular disorders, diabetes, and obesity is a primary driver for the minimally invasive-surgery-devices market. As these conditions often require surgical intervention, the demand for minimally invasive techniques is likely to increase. According to recent data, chronic diseases affect nearly 60% of the US population, leading to a growing need for effective surgical solutions. Minimally invasive procedures are preferred due to their reduced recovery times and lower complication rates, which align with patient preferences for quicker return to daily activities. This trend suggests that healthcare providers are increasingly adopting these devices to meet patient needs, thereby propelling the market forward.

    Technological Innovations in Surgical Devices

    Technological advancements in surgical devices are significantly influencing the minimally invasive-surgery-devices market. Innovations such as robotic-assisted surgery, advanced imaging techniques, and enhanced visualization tools are transforming surgical practices. For instance, the integration of robotics in surgery has been shown to improve precision and reduce recovery times, making procedures safer and more efficient. The market for robotic surgical systems alone is projected to reach approximately $20 billion by 2026. These innovations not only enhance surgical outcomes but also attract more healthcare facilities to adopt minimally invasive techniques, thereby driving market growth.

    Growing Awareness and Acceptance Among Patients

    There is a notable increase in patient awareness and acceptance of minimally invasive surgical procedures, which is positively impacting the minimally invasive-surgery-devices market. Patients are becoming more informed about the benefits of these procedures, including shorter hospital stays, reduced pain, and minimal scarring. Surveys indicate that over 70% of patients prefer minimally invasive options when available. This shift in patient preference encourages healthcare providers to offer more minimally invasive solutions, thus expanding the market. As patients advocate for less invasive options, the demand for innovative surgical devices is expected to rise, further stimulating market growth.

    Market Segment Insights

    By Application: General Surgery (Largest) vs. Gynecological Surgery (Fastest-Growing)

    In the US minimally invasive-surgery-devices market, General Surgery holds the largest share among the application segments, reflecting its broad applicability across various medical procedures. It is followed by Cardiothoracic Surgery, Urological Surgery, and Orthopedic Surgery, which collectively contribute to a significant portion of the market. Gynecological Surgery, while smaller in share, is gaining traction due to increasing awareness and advancements in surgical techniques. The growth trends within the application segment are driven by technological advancements, increasing patient preference for minimally invasive procedures, and a rising number of surgical procedures performed. Gynecological Surgery has emerged as the fastest-growing segment, propelled by innovations in surgical devices that enhance patient outcomes. This growth is also facilitated by the expanding prevalence of gynecological disorders requiring surgical intervention.

    General Surgery (Dominant) vs. Urological Surgery (Emerging)

    General Surgery dominates the US minimally invasive-surgery-devices market due to its widespread use in various surgical procedures, offering manifold benefits, including reduced recovery times and minimized scarring. It serves multiple specialties, which strengthens its market position. In contrast, Urological Surgery, recognized as an emerging segment, is witnessing increasing adoption of minimally invasive techniques. Innovations in robotic surgery and flexible ureteroscopes are enhancing precision and patient comfort. This segment is expanding as more healthcare providers recognize the advantages of these devices, ultimately improving surgical outcomes and driving demand.

    By Product Type: Endoscopes (Largest) vs. Robotic Surgery Systems (Fastest-Growing)

    In the US minimally invasive-surgery-devices market, the distribution of market share reflects a competitive landscape among the product types. Endoscopes currently command the largest share, demonstrating their essential role in minimally invasive procedures. Following closely are Laparoscopic Surgical Instruments and Visualization Systems, which also contribute significantly to the overall market. Access Devices, while integral, hold a smaller proportion as the market evolves and adapts to healthcare demands. Growth trends in the segment indicate a robust increase in the adoption of Robotic Surgery Systems, marking them as the fastest-growing segment driven by technological advancements and a rising preference for precision in surgical procedures. The increasing number of surgical procedures combined with improved reimbursement frameworks further accelerates the demand for these innovative solutions, fostering a progressive shift in surgical practices.

    Endoscopes (Dominant) vs. Robotic Surgery Systems (Emerging)

    Endoscopes represent the dominant product type in the minimally invasive-surgery-devices market, known for their pivotal role in diagnostic and therapeutic procedures. Their versatility and effectiveness contribute to a high usage rate, making them a staple in hospitals and surgical centers. Conversely, Robotic Surgery Systems are emerging rapidly, appealing to healthcare providers through enhanced surgical accuracy and reduced recovery times for patients. These systems are increasingly favored for complex procedures, demonstrating a potential to reshape surgical methodologies. Both product types signify a critical evolution within the market, reflecting the dual focus on established technologies and innovative advancements.

    By End-use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

    Among the end-use segment in the US minimally invasive-surgery-devices market, hospitals hold the largest market share. This is primarily due to their established infrastructure, advanced technological adoption, and the increasing number of surgical procedures being conducted in these facilities. Ambulatory surgical centers, on the other hand, are rapidly gaining traction, driven by the growing demand for outpatient procedures, which promote faster recovery times and reduced healthcare costs. The growth trends in this segment are robust, with ambulatory surgical centers showcasing the fastest expansion. This growth is spurred by several factors, including rising patient preference for less invasive procedures, advancements in surgical technologies, and increased insurance coverage for outpatient surgeries. Specialty clinics, while significant, are positioned to complement the services provided by hospitals and ambulatory centers, thereby playing a crucial role in the overall healthcare ecosystem.

    Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

    Hospitals play a dominant role in the end-use segment of the US minimally invasive-surgery-devices market, characterized by their extensive surgical capabilities and access to a wide range of minimally invasive technologies. These facilities often lead in adopting the latest surgical advancements, ensuring optimal patient outcomes. In contrast, ambulatory surgical centers are emerging as significant players, specifically tailored for outpatient surgeries. These centers are designed for efficiency, enhancing patient flow and reducing waiting times. Their appeal is further heightened by the trend toward outpatient care, which aligns with patient preferences for quicker recovery and lower costs. Both segments are essential, but their operational models cater to different needs within the healthcare landscape.

    By Technology: Transcatheter Aortic Valve Replacement (Largest) vs. Natural Orifice Transluminal Endoscopic Surgery (Fastest-Growing)

    In the US minimally invasive-surgery-devices market, Transcatheter Aortic Valve Replacement (TAVR) holds the largest market share due to its widespread adoption in treating aortic stenosis. It has revolutionized heart valve surgery with its minimally invasive approach, appealing to both patients and healthcare providers. On the other hand, Video-Assisted Thoracoscopic Surgery (VATS) offers notable market presence as well, integrating advanced technology with effective surgical solutions, albeit with a smaller share compared to TAVR. Growth trends in this segment indicate that Natural Orifice Transluminal Endoscopic Surgery (NOTES) is emerging rapidly within the market, driven by advancements in surgical technology and increasing preference for minimally invasive procedures. The rise in cardiovascular diseases further fuels the demand for Transcatheter Aortic Valve Replacement. These segments are growing due to their ability to reduce recovery times, minimize surgical risks, and enhance patient outcomes, positioning them as key players in modern surgical practices.

    Technology: Transcatheter Aortic Valve Replacement (Dominant) vs. Natural Orifice Transluminal Endoscopic Surgery (Emerging)

    Transcatheter Aortic Valve Replacement (TAVR) is at the forefront of minimally invasive surgical technology, providing a less invasive option for high-risk patients with aortic stenosis. Its dominant position in the market is attributed to clinical efficacy and reduced recovery times, reshaping cardiac surgery approaches. In contrast, Natural Orifice Transluminal Endoscopic Surgery (NOTES) is gaining traction as an emerging technique that allows surgeries without external incisions, thereby minimizing post-operative discomfort and reducing complication rates. The innovation and effectiveness of both technologies are pivotal in advancing surgical practices, addressing various patient needs, and subsequently driving market growth.

    Get more detailed insights about US Minimally Invasive Surgery Devices Market

    Key Players and Competitive Insights

    The minimally invasive-surgery-devices market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for patient-centric healthcare solutions. Major players such as Medtronic (US), Johnson & Johnson (US), and Intuitive Surgical (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Medtronic (US) emphasizes its commitment to developing cutting-edge technologies, while Johnson & Johnson (US) leverages its extensive portfolio to integrate minimally invasive solutions across various surgical specialties. Intuitive Surgical (US), known for its robotic-assisted surgical systems, continues to expand its capabilities, thereby shaping the competitive environment through a focus on precision and efficiency.

    Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and innovations, fostering a competitive atmosphere where companies must continuously adapt to maintain their market share.

    In October 2025, Medtronic (US) announced the launch of its latest robotic-assisted surgical platform, which integrates advanced AI capabilities to improve surgical outcomes. This strategic move is likely to enhance Medtronic's competitive edge by providing surgeons with enhanced tools for precision and decision-making, thereby addressing the growing demand for minimally invasive procedures.

    In September 2025, Johnson & Johnson (US) expanded its partnership with a leading telehealth provider to enhance remote surgical consultations. This initiative reflects a strategic focus on digital transformation, enabling healthcare providers to offer more accessible and efficient care. By integrating telehealth solutions, Johnson & Johnson (US) positions itself as a leader in the evolving landscape of minimally invasive surgery, catering to the needs of both patients and healthcare professionals.

    In August 2025, Intuitive Surgical (US) reported a significant investment in R&D aimed at developing next-generation robotic systems. This investment underscores the company's commitment to innovation and its intent to stay ahead of competitors by introducing advanced technologies that improve surgical precision and patient outcomes. Such strategic actions are indicative of a broader trend within the industry, where companies prioritize technological advancements to differentiate themselves in a crowded market.

    As of November 2025, current trends in the minimally invasive-surgery-devices market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, as companies collaborate to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize these aspects will likely emerge as leaders in the market.

    Key Companies in the US Minimally Invasive Surgery Devices Market market include

    Future Outlook

    US Minimally Invasive Surgery Devices Market Future Outlook

    the market is projected to grow at a 9.55% CAGR from 2024 to 2035, driven by technological advancements, increasing patient demand, and cost-effectiveness.

    New opportunities lie in:

    • Development of AI-driven surgical assistance tools
    • Expansion of telemedicine integration for remote surgeries
    • Investment in biodegradable surgical devices for sustainability

    By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

    Market Segmentation

    US Minimally Invasive Surgery Devices Market End-use Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics

    US Minimally Invasive Surgery Devices Market Technology Outlook

    • Video-Assisted Thoracoscopic Surgery
    • Transcatheter Aortic Valve Replacement
    • Natural Orifice Transluminal Endoscopic Surgery

    US Minimally Invasive Surgery Devices Market Application Outlook

    • General Surgery
    • Cardiothoracic Surgery
    • Gynecological Surgery
    • Urological Surgery
    • Orthopedic Surgery

    US Minimally Invasive Surgery Devices Market Product Type Outlook

    • Endoscopes
    • Robotic Surgery Systems
    • Laparoscopic Surgical Instruments
    • Visualization Systems
    • Access Devices

    Report Scope

    MARKET SIZE 2024 1650.0(USD Million)
    MARKET SIZE 2025 1807.57(USD Million)
    MARKET SIZE 2035 4500.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 9.55% (2024 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Million
    Key Companies Profiled Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Olympus Corporation (JP), Smith & Nephew (GB), Intuitive Surgical (US)
    Segments Covered Application, Product Type, End-use, Technology
    Key Market Opportunities Advancements in robotic-assisted surgery enhance precision and reduce recovery time in the minimally invasive-surgery-devices market.
    Key Market Dynamics Technological advancements drive growth in minimally invasive surgery devices, enhancing patient outcomes and operational efficiency.
    Countries Covered US

    Leave a Comment

    FAQs

    What is the expected market size of the US Minimally Invasive Surgery Devices Market in 2024?

    The market is expected to be valued at 8.7 billion USD in 2024.

    What is the projected market size by 2035 for the US Minimally Invasive Surgery Devices Market?

    By 2035, the market is projected to reach 14.5 billion USD.

    What is the expected CAGR for the US Minimally Invasive Surgery Devices Market from 2025 to 2035?

    The expected CAGR for the market during this period is 4.753%.

    Which application holds the largest share in the US Minimally Invasive Surgery Devices Market in 2024?

    General Surgery holds the largest share, valued at 3.5 billion USD in 2024.

    Which key player is significant in the US Minimally Invasive Surgery Devices Market?

    Major players include Medtronic, Boston Scientific, and Johnson & Johnson among others.

    What is the market value for Cardiothoracic Surgery within the US Minimally Invasive Surgery Devices Market in 2024?

    The market value for Cardiothoracic Surgery is 1.8 billion USD in 2024.

    What are the forecasted market sizes for Gynecological Surgery by 2035?

    The market for Gynecological Surgery is forecasted to be 2.5 billion USD by 2035.

    How much is the Urological Surgery segment valued at in 2024?

    The Urological Surgery segment is valued at 1.2 billion USD in 2024.

    What is the expected market value for Orthopedic Surgery by 2035?

    The expected market value for Orthopedic Surgery by 2035 is 1.5 billion USD.

    What significant trends are impacting the growth of the US Minimally Invasive Surgery Devices Market?

    Key trends influencing growth include technological advancements and increasing patient preference for minimally invasive procedures.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions